Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
All content for Can We End Epidemics? is the property of Foreign Policy and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
Health promotion and disease prevention are critical tools needed to eliminate epidemics, yet prevention remains under-resourced and insufficiently prioritized. How can we push prevention up the policy and political agenda so it is a more critical part of primary health care? In this episode, host Henry Bonsu joins Shereen El Feki, a renowned sexpert and the former regional director for the Middle East and North Africa at UNAIDS, and Randevyn Piérre, a regional director in external affairs for ViiV Healthcare, to explore what targeted prevention looks like for those leading the charge to avert HIV transmission, including partnering with community-led responses.
Glossary of terms used this season: https://foreignpolicy.com/podcasts/can-we-end-epidemics/
Can We End Epidemics?
Is it possible to end HIV and global health epidemics as public health threats by 2030? The United Nations thinks so, and the guests on this podcast series certainly hope so. But it’s going to take effort, innovation, connections between people and within communities and funding. Welcome to Can We End Epidemics?, a podcast series by the global biopharmaceutical company ViiV Healthcare in association with its biopharma majority shareholder GSK and developed by FP Studios.
